Persistent symptoms, cognitive impairment, and clinical predictors of long COVID one year after Omicron infection: A clinical case–control study from the Faroe Islands
PLOS One · 2026
DOI: 10.1371/journal.pone.0351564 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Gunnhild Helmsdal und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research, Tórshavn, Faroe Islands. Hauptthemen laut MEDLINE: COVID-19, Cognitive Dysfunction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Heilsutrygd, Betri Stuðul.
Abstract (Originalsprache)
Background
Six years since the emergence of SARS-CoV-2, the newer variants of the virus continue to have long-term health effects.
Objectives
The aim of the study was to investigate persistent symptoms, cognitive impairment, and clinical and paraclinical predictors of long COVID in individuals infected during the Omicron wave.
Methods
We conducted a clinical case-control study including participants with persistent symptoms up to 13 months after confirmed SARS-CoV-2 Omicron infection (long COVID or LC group) and antibody-verified never-infected controls (NI group).
Results
A total symptom score based on a 24-item questionnaire was strongly associated with increased odds of long COVID (adjusted odds ratio (aOR) 1.21, 95% CI 1.13–1.30, p < 0.001). Sub-analysis showed particularly strong associations for fatigue, cognitive impairment, neurological symptoms, and symptoms from the cardiopulmonary and musculoskeletal systems. Both mental impairment and fatigue independently predicted long COVID (aOR 1.27, 95% CI 1.14–1.42, p < 0.001, and aOR 1.27, 95% CI 1.11–1.46, p < 0.001, respectively). Additionally, a higher number of self-reported infections during the follow-up period increased the odds of long COVID (aOR 1.57, 95% CI 1.06–2.34, p = 0.025), though this was not reflected in antibiotic use. Finally, blood analyzes showed that lower white blood cell counts were associated with increased odds of long COVID in women, but not in men, however the clinical significance of this finding remains uncertain.
Conclusions
One year after Omicron infection, a subset of people continue to experience a substantial symptom burden, particularly fatigue, cognitive impairment, and mental well-being, and a higher frequency of intercurrent infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Research, Tórshavn, Faroe Islands.
- Medical Department, National Hospital, Tórshavn, Faroe Islands.
- University of the Faroe Islands, Tórshavn, Faroe Islands.
ORCID-Profile: Gunnhild Helmsdal, Marnar Fríðheim Kristiansen
Förderung
- Heilsutrygd
- Betri Stuðul
Zitieren
APA
Helmsdal, G., Kristiansen, M. F., Gaard, E. K., Eysturoy, B. J., Weihe, P., Eliasen, E. H., & Petersen, M. S. (2026). Persistent symptoms, cognitive impairment, and clinical predictors of long COVID one year after Omicron infection: A clinical case–control study from the Faroe Islands. PLOS One. https://doi.org/10.1371/journal.pone.0351564
Vancouver
Helmsdal G, Kristiansen MF, Gaard EK, Eysturoy BJ, Weihe P, Eliasen EH, et al. Persistent symptoms, cognitive impairment, and clinical predictors of long COVID one year after Omicron infection: A clinical case–control study from the Faroe Islands. PLOS One. 2026. doi:10.1371/journal.pone.0351564
BibTeX
@article{Helmsdal2026,
author = {Helmsdal, Gunnhild and Kristiansen, Marnar Fríðheim and Gaard, Eyðbjørg Klemmentsen and Eysturoy, Barbara Joensen and Weihe, Pál and Eliasen, Eina Hansen and Petersen, Maria Skaalum},
title = {Persistent symptoms, cognitive impairment, and clinical predictors of long COVID one year after Omicron infection: A clinical case–control study from the Faroe Islands},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0351564}
}
EUVIMED